rs267606706
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_005188.4(CBL):c.1111T>A(p.Tyr371Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000069 in 1,450,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y371D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_005188.4 missense
Scores
Clinical Significance
Conservation
Publications
- CBL-related disorderInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, Genomics England PanelApp
- juvenile myelomonocytic leukemiaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Noonan syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005188.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CBL | NM_005188.4 | MANE Select | c.1111T>A | p.Tyr371Asn | missense | Exon 8 of 16 | NP_005179.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CBL | ENST00000264033.6 | TSL:1 MANE Select | c.1111T>A | p.Tyr371Asn | missense | Exon 8 of 16 | ENSP00000264033.3 | ||
| CBL | ENST00000634586.1 | TSL:5 | c.1111T>A | p.Tyr371Asn | missense | Exon 8 of 18 | ENSP00000489218.1 | ||
| CBL | ENST00000637974.1 | TSL:5 | c.1105T>A | p.Tyr369Asn | missense | Exon 8 of 17 | ENSP00000490763.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1450022Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 722298 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Pathogenic:1
Noonan syndrome 1 Pathogenic:1
CBL-related disorder Pathogenic:1
PS2, PM2, PM5
Neurodevelopmental disorder Pathogenic:1
RASopathy Pathogenic:1
This variant is not present in population databases (gnomAD no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Tyr371 amino acid residue in CBL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20543203, 20694012, 25283271, 25952305, 28414188). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CBL protein function. ClinVar contains an entry for this variant (Variation ID: 180827). This missense change has been observed in individual(s) with cerebral arteriopathy and/or juvenile myelomonocytic leukemia (PMID: 20694012, 28343148). This sequence change replaces tyrosine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 371 of the CBL protein (p.Tyr371Asn).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at